Sanofi reported EUR2.63B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Aena EUR 170.14M 8.19M Mar/2025
Alcon AG USD 870M 57M Jun/2025
Almirall EUR 91.3M 55.52M Mar/2025
Amarin USD 36.57M 397K Mar/2025
Amgen USD 1.69B 4M Jun/2025
AstraZeneca USD 5.01B 1.42B Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Biogen USD 583.8M 11.3M Jun/2025
BMW EUR 2.7B 311M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Eli Lilly USD 2.75B 390.8M Jun/2025
Essilor EUR 1.09B 2.08B Jun/2025
Fresenius EUR 740M 97M Jun/2025
Fresenius Medical Care EUR 792M 41M Jun/2025
Galapagos EUR 30.67M 13.12M Jun/2025
Genmab DKK 144M 18M Jun/2025
Gilead Sciences USD 1.36B 100M Jun/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
GRIFOLS EUR 282.76M 41.9M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
J&J USD 5.89B 777M Jun/2025
Mercedes-Benz AG EUR 3.12B 62M Jun/2025
Merck EUR 1.48B 9M Jun/2025
Merck USD 2.63B 104M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Novo Nordisk 18.85B 2.74B Jun/2025
Orion EUR 96.7M 12.4M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Philips EUR 1.24B 9M Jun/2025
Recordati EUR 186.98M 5.59M Jun/2025
Regeneron Pharmaceuticals USD 634.2M 1.2M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sanofi EUR 2.63B 408M Jun/2025
Sanofi EUR 2.32B 1.08B Jun/2025
SAP EUR 2.22B 370M Jun/2025
UCB EUR 1.29B 221M Dec/2024
Vinci EUR 197M 49M Jun/2025
Volkswagen EUR 8.73B 44M Jun/2025